Up to 88 percent fewer new drug approvals projected in study commissioned by Biocom and California Life Sciences Association.
Drug pricing bill will stop innovative new medicines, California trade groups say
Up to 88 percent fewer new drug approvals projected in study commissioned by Biocom and California Life Sciences Association.
